| Angela A Folsom, RPH | |
|
85 State Route 101a, Amherst, NH 03031-2216 | |
| (603) 672-2021 | |
| (603) 672-3405 |
| Full Name | Angela A Folsom |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 85 State Route 101a, Amherst, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063628568 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3233 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela A Folsom, RPH 76 Gosselin Rd, Manchester, NH 03103-6145 Ph: (603) 644-5639 | Angela A Folsom, RPH 85 State Route 101a, Amherst, NH 03031-2216 Ph: (603) 672-2021 |
News Archive
A feature article in the Ugandan Observer examines a recent agreement signed by the U.S. and Ugandan governments "to drum up more support for maternal and reproductive health in Uganda." U.S. Global Health Initiative (GHI) Executive Director Lois Quam spoke at the signing, saying, "Investment in health in Uganda is one of the largest we make anywhere else in the world. Government must do more.
​Dermatology researcher Nicole Ward, PhD, has earned her third National Institutes of Health grant in a year - including two that scored in the first percentile. With this most recent award, an R21, she will investigate the role the nervous system plays in psoriasis - an inflammatory autoimmune disease characterized by raised areas of red, scaly, itchy and sometimes painful patches of skin.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today presented pharmacokinetic and pharmacodynamic data along with the previously reported statistically significant clinical results from its Phase 2b clinical trial of EVP-6124, a novel alpha-7 agonist, in patients with Alzheimer's disease.
The first findings from a one-of-a-kind, patient-driven effort to provide lung tissue for research might help doctors predict when patients with idiopathic pulmonary fibrosis (IPF) are becoming dangerously ill and also could point the way to interventions that could sustain them until life-saving transplants can be performed.
Results of a new EADV survey released today show that almost half (47.9%) of the European general population more than 18 years old declared at least one dermatological condition in the past 12 months.
› Verified 5 days ago
Dr. Emma Fontaine, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 85 State Route 101a, Amherst, NH 03031 Phone: 603-672-2021 | |
Mrs. Jennifer Anne Sylvester, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 85 Route 101a, Amherst, NH 03031 Phone: 603-672-2021 | |
Lauren Taylor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 85 Route 101a, Amherst, NH 03031 Phone: 603-672-2021 | |
Melissa Ann Leonard, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 85 Route 101a, Amherst, NH 03031 Phone: 603-672-2021 |